The future of Digital Therapeutics (DTx): Perspectives and market projections by Ana Díaz-Roncero, January 22, 2025 Digital Therapeutics (DTx), clinically evaluated software designed to prevent, diagnose, or treat diseases, are transforming healthcare. These tools...
Evolution of Digital Health: What has changed and what do we expect? by Pedro Vergara, December 11, 2024 The COVID-19 pandemic created a “before” and an “after” in many areas, without a doubt including Digital Health. The pandemic conditions promoted telemedicine,...
What are the benefits of fast-track approval for Digital Therapeutics (DTx)? by Pedro Vergara, October 30, 2024 As we have seen, Digital Therapeutics (DTX) go one step beyond Digital Health tools, becoming clinically validated solutions that meet the technical...
What can Digital Health do in Oncology? by Ana Díaz-Roncero and Patricia Domínguez, October 2, 2024 For many years, cancer has been one of the largest and most significant categories of disease around the world. In 2020, 18.1 million new cases of cancer were diagnosed...
Digital Health in Heart Failure: Optimizing results with fewer resources by Pedro Vergara, September 4, 2024 Heart Failure, also known as cardiac insufficiency, is considered by many experts to be a true epidemic. On a global level, it affects 64 million people, and...
How are Digital Therapeutics (DTx) making headway in the Spanish Health System? by Ana Díaz-Roncero, July 24, 2024 Over the past few years, Digital Therapeutics (DTx) (software that has been clinically validated and supported with scientific evidence used to prevent,...
